Emerging markets are forecast to help bring stability to ailing solar industry,with up to 12GW of new solar capacity added in 2017 up from just 1.6GW in 2012,according to IMS Research.The research institute's latest study evaluated the ...
Tags: solar industry, Emerging market, solar capacity, IMS
Closer partnerships between textile recyclers, local authorities and waste management companies can play a major role in diverting greater volumes of discarded clothing and household textiles from landfill, delegates at the UK’s ...
Tags: United Kingdom, Textile Recycling
Emerging markets are forecast to help bring stability to the solar industry,with up to 12GW of new photovoltaic capacity added in 2017,up from just 1.6GW in 2012,according to an IHS solar report. The study,which evaluated the potential ...
Tags: solar industry, new photovoltaic capacity, IHS solar report, markets
The US Patent and Trademark Office(USPTO)has granted two new patents including Patent No.8,252,328 and Patent No.8,252,329 to AcelRx Pharmaceuticals'small-volume oral transmucosal dosage forms. The 8,252,328 patent covers delivery of ...
Tags: two new patents, 328, Patent No.8, 252, 329, AcelRx Pharmaceuticals
The UAE's Dana Gas has signed agreements with the Sharjah and Ajman governments to develop a gas field located about 40 km offshore in shared territorial waters, the company said in a statement Thursday. The agreements include a ...
The Ministry of Energy and Water Resources will establish an inter-ministerial team to promote the construction of a compressed natural gas(CNG)infrastructure,which will supply gas to Phoenicia America-Israel(Flat Glass)Ltd.and other ...
Tags: Phoenicia Flat Glass, CNG, natural gas pipeline, Flat Glass
New Look Retail Group Limited announces Interim Results for the 26 weeks ended 22 September. Interim Results Financial Headlines H1 EBITDA: £86.9m (H1 2011/12: £69.4m): +25.2% H1 Group Sales: £710.5m (H1 ...
Tags: United Kingdom, New Look Posts
VentiRx Pharmaceuticals has formed a world-wide collaboration with Celgene Corporation to develop VTX-2337, a highly potent and selective TLR8 agonist for cancer treatment. As part of the agreement, Celgene will fund $35m as upfront ...
Optical components, modules and subsystems developer Oclaro of San Jose, CA, USA has reported financial results for its fiscal first-quarter 2013 (ended 29 September 2012), including about ten weeks of operating results of Opnext Inc of ...
Tags: Oclaro Opnext, Quarterly Earnings Slip, financial results
Elite Pharmaceuticals has shipped Phendimetrazine tartrate 35 mg tablets as part of the previously announced manufacturing and supply agreement with Mikah Pharma. As part of a distribution agreement between Mikah and Actavis, Actavis ...
Tags: Phendimetrazine tartrate, Elite Pharmaceuticals, Bontril PDM
Author(s): Rob Mosher Author(s): Nicole Steele Transportation Reauthorization Approved After months of intense negotiations, on June 29th Congress cleared a bill (H.R. 4348) that will ensure funding for highway and mass transit projects ...
Tags: ransit projects, Transportation Reauthorization, Farm Bill
Specialty pharmaceutical company Intelliject has received the US Food and Drug Administration(FDA)approval for its Auvi-Q(epinephrine injection,USP)used in the emergency treatment of life-threatening allergic reactions in people who are at ...
Tags: Specialty pharmaceutical company, Auvi-Q, Spencer Williamson, FDA
Biogen Idec (BIIB) and Isis Pharmaceuticals have entered into an exclusive, worldwide option and collaboration agreement, pursuant to which the companies will develop and commercialize a novel antisense drug for the treatment of myotonic ...
Tags: Steinert Disease, antisense drug
Pulmatrix has announced the results of a clinical study showing that an iCALM (inhaled cationic airway lining modulator therapy) attenuated allergen-induced bronchitis in susceptible asthmatic patients. The study concluded that iCALM is a ...
GlaxoSmithKline (GSK) has entered into a drug discovery alliance with Yale to design a potential new class of medicines that degrade disease-causing proteins. Under the collaboration, GSK integrates its expertise in medicinal chemistry ...
Tags: Yale University, Drug Discovery Alliance, protein-degrading drug